NEW YORK--(BUSINESS WIRE)--Lev Pharmaceuticals, Inc. (“Lev” or the “Company”) (OTCBB:LEVP) announced today that Joshua Schein, Ph.D., chief executive officer of Lev will present at the Rodman and Renshaw 5th Annual Global Healthcare Conference, being held May 19-20 at the Le Meridien Beach Plaza Hotel in Monte Carlo, Monaco. Dr. Schein will present a corporate progress report, including an update on the Company’s lead product candidate, Cinryze™ (C1 inhibitor). The Lev presentation is scheduled to begin at 3:20 PM Central European Summer Time on Tuesday, May 20th.
